New 'Artificial Pancreas' system enters human testing
NCT ID NCT07227805
Summary
This study is testing a new, experimental automated insulin delivery system (called the MiniMed NMX8) for people who require insulin for diabetes. It will compare the new system to a currently available one (the MiniMed 780G) to see if it is safe and performs just as well or better at keeping blood sugar in a healthy range. About 116 people, including children as young as 2, who already use the 780G system will participate.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES (INSULIN-REQUIRING, TYPE 1 OR TYPE 2) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.